Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2024Current OncologyOpen Access

Real-World Analysis of the Clinical and Economic Impact of the 21-Gene Recurrence Score (RS) in Invasive Lobular Early-Stage Breast Carcinoma in Ireland

View Full Paper
Ask AI
Bookmark
Share

Authors

LMLynda McSorleyBeaumont HospitalMTMehala TharmabalaSt. Vincent's University HospitalFRFathiya Al RahbiSultan Qaboos University Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

McSorley et al. (2024) studied this question.

synapsesocial.com/papers/68e764b2b6db6435876dad12https://doi.org/10.3390/curroncol31030098
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer2019 · 564 citations
  2. 2Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer2018 · 2,450 citations
  3. 3Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome2004 · 880 citations
  4. 4A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer2004 · 6,424 citations
  5. 5Population-Based Validation of the Prognostic Model ADJUVANT! for Early Breast Cancer2005 · 574 citations